Yamanaka Osamu, Saika Shizuya, Ikeda Kazuo, Miyazaki Ken-Ichi, Ohnishi Yoshitaka, Ooshima Akira
Department of Ophthalmology, Wakayama Medical University, Wakayama, Japan.
Curr Eye Res. 2006 Jun;31(6):491-9. doi: 10.1080/02713680600701380.
We examined the role of interleukin-7 (IL-7) in modulation of production of extracellular matrix (ECM), immunolocalization of Smads, and cell migration and expressions of transforming growth factor-beta (TGF-beta) in cultured human subconjunctival fibroblasts. IL-7 is capable of inducing Smad7, an inhibitory Smad that interferes with TGF-beta/Smad signal.
The effects of IL-7 on ECM production, immunolocalization of Smads, type I collagen, fibronectin, alpha -smooth muscle actin (alpha -SMA), and cell migration were examined in human subconjunctival fibroblast culture with or without TGF-beta1. ECM production, such as type I collagen and fibronectin, was measured by immunoassay or real-time reverse transcriptase-polymerase chain reaction (RT-PCR). Cell migration was examined using an in vitro wound model in monolayer cultures. We also examined the effects of IL-7, PKC inhibitor, and STAT inhibitor on the expressions of TGF-beta1 and type I collagen alpha1 chain (col1A1) m-RNA by using real-time RT-PCR.
IL-7 reduced the ECM production much more markedly in the cells treated with TGF-1beta than in the control fibroblasts. TGF-beta1 strongly showed immunolocalization of phospho-Smad2, and IL-7 also showed immunolocalization of Smad7 in the nuclei. The immunoreactivities of alpha -SMA and fibronectin were weaker in the presence of IL-7 than in the control cells. IL-7 also delayed defect closure in the monolayer cell sheets, and the delay was recovered by exogenous type I collagen or fibronectin. Each of IL-7, BIS I, or AGS 490 reduced the mRNA expressions of TGF-beta1 and col1A1.
These findings indicate that IL-7 is involved in ECM production in the subconjunctival fibroblasts activated by exogenous TGF-beta1, suggesting that administration of IL-7 can be a novel therapeutic strategy in preventing undesirable bleb scar formation during healing after filtration surgery.
我们研究了白细胞介素-7(IL-7)在调节细胞外基质(ECM)产生、Smads免疫定位、细胞迁移以及培养的人结膜下成纤维细胞中转化生长因子-β(TGF-β)表达方面的作用。IL-7能够诱导Smad7,一种干扰TGF-β/Smad信号的抑制性Smad。
在有或无TGF-β1的人结膜下成纤维细胞培养物中,检测IL-7对ECM产生、Smads免疫定位、I型胶原、纤连蛋白、α-平滑肌肌动蛋白(α-SMA)和细胞迁移的影响。通过免疫测定或实时逆转录-聚合酶链反应(RT-PCR)测量ECM产生,如I型胶原和纤连蛋白。使用单层培养中的体外伤口模型检测细胞迁移。我们还通过实时RT-PCR检测了IL-7、蛋白激酶C(PKC)抑制剂和信号转导子和转录激活子(STAT)抑制剂对TGF-β1和I型胶原α1链(col1A1)mRNA表达的影响。
与对照成纤维细胞相比,IL-7在经TGF-β1处理的细胞中更显著地降低了ECM产生。TGF-β1强烈显示磷酸化Smad2的免疫定位,IL-7也显示Smad7在细胞核中的免疫定位。在存在IL-7的情况下,α-SMA和纤连蛋白的免疫反应性比对照细胞弱。IL-7还延迟了单层细胞片的缺损闭合,并且通过外源性I型胶原或纤连蛋白恢复了延迟。IL-7、双吲哚马来酰胺I(BIS I)或490氨基胍(AGS 490)中的每一种都降低了TGF-β1和col1A1的mRNA表达。
这些发现表明IL-7参与了由外源性TGF-β1激活的结膜下成纤维细胞中的ECM产生,提示给予IL-7可能是一种预防滤过手术后愈合过程中不良滤过泡瘢痕形成的新治疗策略。